Notably, the analysis revealed that SLC7A7 expression was significantly correlated with prognosis in six types of cancer, including multiple myeloma, prostate, colorectal, glioma, breast and lung cancer (Fig. 3a–h). Here, SLC7A7 is linked to lung cancer.